Tue 20 Oct 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Study Title | Study Sponsor | Status | Study Drug | Trial Phase | Study Protocol Number | Site |
|---|---|---|---|---|---|---|
| Superiority of Insulin Glargine Lantus vs. NPH: Treat to Normoglycemia Concept.Effect of Insulin Glargine in Comparison to Insulin NPH in Insulin-nave People With Type 2 Diabetes Mellitus Treated With at Least One OAD and Not Adequately Controlled | Sanofi | Ongoing | Lantus® | 4 | Lantu_C_02762 | King Abdulaziz University Hospital (Jeddah), King Fahad University Hospital (Al-Khobar) |
| Registry in the management of Acute Diarrhea in Children : Observational study in Daily practice | Sanofi | Ongoing | N/A | 4 | DIREG_R_06373 | King Fahad Medical City (Riyadh) |
| Unmet needs in allergic rhinitis: International Survey on Mangment of Allergic Rhinitis by Physician and Patient. | Sanofi | Ongoing | N/A | 4 | DIREG_R_06411 | Soliman Fakeeh Hospital (Jeddah) |
| International Diabetes Management Practice Study - IDMPS | Sanofi | Ongoing | N/A | 4 | DIREG_R_05168 | King Fahad Hospital (Jeddah) |
| Venous Thromboembolic Risk Assessment of Post-Partum Females in Saudi Arabia Utilizing Royal College of Obstetrics and Gynecology Risk Assessment Model | Sanofi | Ongoing | N/A | 4 | DIREG_L_06410 | King Abdulaziz University Hospital (Jeddah) |
| The Influence of a rapid relief of gastro esophageal reflux disease (GERD) symptoms on the quality of life and patient satisfaction after initiating treatment with a Proton Pump Inhibitor. | Sanofi | Ongoing | N/A | 4 | DRIEG_L_05705 | University District Hospital (Jeddah) |
| An observational registry improving Control of Hypertension and Achieving Normalization Goal Earlier | Sanofi | Ongoing | N/A | 4 | DIREG_L_05059 | Erfan & Bagedo General Hospital (Jeddah) |
| An observational study to monitor the efficacy and tolerability of levofloxacin 250 mg OD for treatment of simple lower UTI in Saudi Arabia | Sanofi | Ongoing | Levofloxacin | 4 | LEVOF_L_05172 | Erfan & Bagedo General Hospital (Jeddah) |
| International Diabetes Management Practices Study (Wave 5) | Sanofi | Ongoing | N/A | 4 | DIREG_R_05941 | King Fahad Hospital (Jeddah) |
| A randomized, double-blind, placebo-controlled phase II study to investigate the efficacy and safety of riociguat (0.5 mg, 1.0 mg, 1.5 mg, 2.0 mg and 2.5 mg TID) in patients with symptomatic pulmonary hypertension associated with idiopathic interstitial pneumonias (IIP). | Bayer | Completed | Riociguat | 2 | BAY 63-2521 / 13605 | King Fahad Medical City (Riyadh), King Khalid University Hospital (Riyadh) |
Last update date: 06/10/2026 at 08:14 AM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.